I Told You So... 🚀

PLUS: Discounts on Dividends 💰

 Gainers📈 & Losers📉

Our Biggest Gainers & Losers of the Day in the $100,000 Build Portfolio

For the 2nd July 2024:

  • I Told You So… 🚀

  • Discounts on Dividends 💰

0.68% Gain Today on the Portfolio… click on me to see my live portfolio!

I Told You So… 🚀

I said this in yesterdays email. And I quote:

But all that said, given the positive sentiment of the market today, if deliveries beat expectations we could see another strong rally”

Deliveries beat expectations & Tesla flew

And that’s exactly what happened.

Expectations were 420,000 cars delivered. The actual number was 443,956 cars.

Cue the near 10% rally.

Now the delivery numbers were still lower than the same quarter last year but only marginally. And considering demands for EVs have dampened as a whole, we’ll chalk that up as a win.

That pushes my holding in Tesla up to $80 which is just under 2% of the portfolio. Also brings me up to 20% profit on the position & makes them my 10th largest holding.

Like I’ve been saying, I still think we’ve got plenty of room to grow yet. You could cull your positions a little on the back of this rally but if I’ve learnt anything from Tesla over the years, it’s this.

It always has more steam than you think it does.

Diamond hands & looking for to the robotaxi events for August.

Sponsored
TheWhiteBox by Nacho de GregorioThe newsletter to stay ahead of the curve in AI

Discounts on Dividends 💰

ABBV is our biggest loser today, down just over 2.5%

ABBV letting the side down today

There’s nothing sinister in the news causing it. It looks like a natural cooling off after a near 12% rally since the start of June.

ABBV is a solid buy even though they’ve had a few red days in a row now. I always think if you feel good about a stock while it’s going up, you should feel extra good when it’s going down.

You’re getting a discount on something you like. Maybe even love.

Future growth looks promising. They’ve got a solid pipeline of products, particularly in immunology and oncology. Those are super high demand areas of medicine.

The acquisition of Allergan boosts their portfolio with Botox and other aesthetic products, mixing up the revenue streams.

ABBV also have a super healthy dividend yield sitting at 3.69% for the income investors among us.

Only a small holding for now but I’ll be looking to grow this over time

My current holdings in ABBV are very small - only 0.75% of my account. But if the price keeps looking for a lower support, I’ll likely be looking to double up on this position size.

That’s all! See you same time tomorrow week 👋 

P.S Hit reply & let me know what you thought of today’s newsletter. All feedback is welcomed ❤️

Reply

or to participate.